JPRN-jRCT2080220116未知Unknown
A phase 1/2 trial of Oxaliplatin(L-OHP) + S-1 in patients with previously untreated advanced colorectal cancer
适应症
试验速览
- 阶段
- Unknown
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old(—)
- 性别
- All
入选标准
- •Histologically proven colorectal cancer
- •Unresectable and advanced colorectal cancer
- •Neither prior chemotherapy,immunotherapy nor prior radiotherapy
- •Age between 20 and 75 years old
- •Performance Status(ECOG scale):0-1
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Phase II study of S-1 plus oxaliplatin (130 mg/m2, every 3 weeks) for advanced gastric cancerJPRN-UMIN000016973Shizuoka Cancer Center25
已完成
1 期
A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal CarcinomaColorectal CancerJPRN-UMIN000017450Japan Clinical Cancer Research Organization45
未知
3 期
Randomized phase III study of S-1 plus oxaliplatin compared with S-1 plus cisplatin as first-line therapy for advanced or recurrent gastric cancerAdvanced or recurrent gastric cancerJPRN-jRCT2080220988Yakult Honsha Co.,Ltd.
已完成
1 期
Phase l and Phase ll Study of S-1+oxaliplatin (SOX)+cetuximab as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild typeMetastatic colorectal cancerJPRN-UMIN000007022Japan Clinical Cancer Research Organization56
已完成
3 期
Phase III Adjuvant Chemotherapy of S-1 plus Oxaliplatin for Colorecrtal Cancer (ACTS-CC 02)JPRN-jRCT1080221040Taiho Pharmaceutical Co., Ltd.1,200
